Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ressenti du Patient au Moment de l'Annonce du Diagnostic de DMLA

NCT03035461 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal Creteil as lead sponsor.

NCT NCT03035461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03035461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ressenti du Patient au Moment de l'Annonce du Diagnostic de DMLA
Lead sponsor
Centre Hospitalier Intercommunal Creteil
Phase
Observational
Overall status
Completed
Start date
March 15, 2017
Completion date
October 19, 2018
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration